Common use of DRUG INFORMATION Clause in Contracts

DRUG INFORMATION. In order to achieve rotation goals and objectives, the resident will complete the following activities: • Respond both verbally and in writing to drug information requests that support patient care and research activities. o Document each of these “informal” drug information requests and their associated response using the departmental intervention software, Theradoc. o Provide written responses to a minimum of 2 researched drug information question of at least moderate complexity by the end of the residency year (at least 1 completed by the second quarter). The expectation is that this will be of quality for submission for publication. o Written responses may be directed to questions encountered and researched during clinical rotations and/or weekend staffing assignments. • Prepare and present at least one (1) unbiased formulary monograph or class review to guide the Pharmacy and Therapeutics Committee (and associated sub-committees) in their formulary decisions. • Co-ordinate and present to the Pharmacy and Therapeutics Committee (and associated sub- committees) at least one (1) medication use evaluation. • Design and implement an intervention to change a problematic or potentially problematic aspect of the medication-use system with the objective of improving quality. • Develop or modify at least one (1) medication use policies. These policies may pertain to the resident’s project, MUE, formulary monograph, or quality improvement project if applicable. • Educate staff on pertinent drug topics. o Provide in-service education as requested. • Actively participate in the institution’s Adverse Drug Event Reporting Program. o Document all identified ADRs in Patient Safety Network (PSN) o Document all identified near misses and medication events using the online ADE reporting program (PSN).

DRUG INFORMATION. In order to achieve rotation goals and objectives, the resident will complete the following activities: • Respond both verbally and in writing to drug information requests that support patient care and research activities. o Document each of these “informal” drug information requests and their associated response using the departmental intervention software, Theradoc. Theradoc®. o Provide written responses to a minimum of 2 researched drug information question of at least moderate complexity by the end of the residency year (at least 1 completed by the second quarter). The expectation is that this will be of quality for submission for publication. o Written responses may be directed to questions encountered and researched during clinical rotations and/or weekend staffing assignments. • Prepare and present at least one (1) unbiased formulary monograph or class review to guide the Pharmacy and Therapeutics Committee (and associated sub-committees) in their formulary decisions. • Co-ordinate and present to the Pharmacy and Therapeutics Committee (and associated sub- committees) at least one (1) medication use evaluation. • Design and implement an intervention to change a problematic or potentially problematic aspect of the medication-use system with the objective of improving quality. • Develop or modify at least one (1) medication use policies. These policies may pertain to the resident’s project, MUE, formulary monograph, or quality improvement project if applicable. • Educate staff on pertinent drug topics. o Provide in-service education as requested. • Actively participate in the institution’s Adverse Drug Event Reporting Program. o Document all identified ADRs in Patient Safety Network (PSN) the institution’s Adverse Drug Event Reporting Program. o Document all identified near misses and medication events using the online ADE reporting program (PSN)in the institution’s Adverse Drug Event Reporting Program.

DRUG INFORMATION. In order to achieve rotation goals and objectives, the resident will complete the following activities: •  Respond both verbally and in writing to drug information requests that support patient care and research activities. o Document each of these “informal” drug information requests and their associated response using the departmental intervention software, Theradoc. Theradoc. o Provide written responses to a minimum of 2 researched drug information question of at least moderate complexity by the end of the residency year (at least 1 completed by the second quarter). The expectation is that this will be of quality for submission for publication. o Written responses may be directed to questions encountered and researched during clinical rotations and/or weekend staffing assignments. •  Prepare and present at least one (1) unbiased formulary monograph or class review to guide the Pharmacy and Therapeutics Committee (and associated sub-committees) in their formulary decisions. •  Co-ordinate and present to the Pharmacy and Therapeutics Committee (and associated sub- committees) at least one (1) medication use evaluation. •  Design and implement an intervention to change a problematic or potentially problematic aspect of the medication-use system with the objective of improving quality. •  Develop or modify at least one (1) medication use policies. These policies may pertain to the resident’s project, MUE, formulary monograph, or quality improvement project if applicable. •  Educate staff on pertinent drug topics. o Provide in-service education as requested. •  Actively participate in the institution’s Adverse Drug Event Reporting Program. o Document all identified ADRs in Patient Safety Network (PSN) o Document all identified near misses and medication events using the online ADE reporting program (PSN).

DRUG INFORMATION. In order to achieve rotation goals and objectives, the resident will complete the following activities: • Respond both verbally and in writing to drug information requests that support patient care and research activities. o Document each of these “informal” drug information requests and their associated response using the departmental intervention software, Theradoc. Theradoc®. o Provide written responses to a minimum of 2 researched drug information question of at least moderate complexity by the end of the residency year (at least 1 completed by the second quarter). The expectation is that this will be of quality for submission for publication. o Written responses may be directed to questions encountered and researched during clinical rotations and/or weekend staffing assignments. • Prepare and present at least one (1) unbiased formulary monograph or class review to guide the Pharmacy and Therapeutics Committee (and associated sub-committees) in their formulary decisions. • Co-ordinate and present to the Pharmacy and Therapeutics Committee (and associated sub- committees) at least one (1) medication use evaluation. • Design and implement an intervention to change a problematic or potentially problematic aspect of the medication-use system with the objective of improving quality. • Develop or modify at least one (1) medication use policies. These policies may pertain to the resident’s project, MUE, formulary monograph, or quality improvement project if applicable. • Educate staff on pertinent drug topics. o Provide in-service education as requested. • Actively participate in the institution’s Adverse Drug Event Reporting Program. o Document all identified ADRs in Patient Safety Network (PSN) o Document all identified near misses and medication events using the online ADE reporting program (PSN).